CORCEPT THERAPEUTICS INC's Relacorilant for Hypercortisolism — FDA decision expected July 11, 2026.
Run-up into the PDUFA
Daily close so far, T-120 through today. High $94.04, low $32.15. Run-up to date +99.4%. Decision 7/11/26. Historical price action, not a forecast.
Key facts
PDUFA date2026-07-11
Business days away1
Drug / candidateRelacorilant
IndicationHypercortisolism
CompanyCORCEPT THERAPEUTICS INC
Market-cap tierLarge
Cohort decision-day move (history)±1% median
Cohort move is the historical median absolute decision-day move for this market-cap tier — history, not a prediction. See the full 2026 PDUFA calendar →